Taken together, the frequencies of blood CD4+ cTfh and circulating CD8+ follicular T cells are highly variable but, on average, not different between RA-risk individuals and early RA patients compared with healthy controls (HCs). This evidence concerns the gene CD8A and rheumatoid arthritis.